Transforming lives by developing drug candidates to treat disruption of neuronal signaling.
Innovative Solutions in Biopharmaceuticals
Transforming lives by developing drug candidates to treat disruption of neuronal signaling.
Transforming lives by developing drug candidates to treat disruption of neuronal signaling.
Transforming lives by developing drug candidates to treat disruption of neuronal signaling.
At EndeavourRx, we strive to revolutionize the biopharmaceutical landscape by developing cutting-edge solutions that enhance health and wellness. Our commitment to innovation drives us to explore new frontiers in medical research and biotechnology.
On September 23, 2025, RespireRx received a Notice of Award from the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), award number 1R44NS143576, under the Small Business Innovation Research (SBIR) program which was created by the U.S. Congress to strengthen the role of small innovative companies in federally supported research and development.
126 Valley Road, Suite C, Glen Rock, NJ 07452
Jeff Margolis +1.9178347206 jmargolis@endeavourrx.com
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.